JPRN-UMIN000014954已完成未知
Cohort study evaluating the efficacy of denosumab to protect against aromatase inhibitor-induced bone loss in Japanese breast cancer patients. - Cohort study evaluating the efficacy of denosumab to protect against aromatase inhibitor-induced bone loss in Japanese breast cancer patients. (CYBORG003)
CYBORG (Chiba Youth Breast Oncology Research Group)0 个研究点目标入组 500 人开始时间: 2014年8月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
The number of registered patient is too small than expected, so we are unable to make a planned analysis.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. Subject with prior allergy history to therapeutic agents used in this study 2. Evidence of with hypocalcemia 3. Known renal deficiency 4. Any organic or psychiatric disorder that, in the opinion of the investigator, might prevent the subject from completing the study or interfere with the interpretation of the study results.
研究者
相似试验
已完成
4 期
Efficacy of coronary artery calcification on DenosumabPatients with osteoporosis with coronary artery calcificationosteoporosis, coronary artery calcificationJPRN-jRCT1031190025Kubota Naoki1
已完成
2 期
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
进行中（未招募）
1 期
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis. FREEDOM (Fracture REduction Evaluation of Denosumab in Osteoporosis every 6 Months)Treatment of postmenopausal osteoporosisMedDRA version: 8.1 Level: LLT Classification code 10031285 Term: Osteoporosis postmenopausalEUCTR2004-000138-35-GBAmgen Inc7,869
已完成
不适用
Multi-center study for evaluating distribution of RHI in Japanese subjects without cardiovascular diseases for estimating clinical reference value of RHI in JapaJPRN-UMIN000021454Jinnouchi Hospital20
已完成
2 期
Trial of the effectiveness of nutritional intervention for patients who are administered TS-1 after surgical resection of pancreatic cancerpancreatic cancerJPRN-jRCT1051180068Toyama Hirochika35